论文部分内容阅读
目的观察米索前列醇联合米非司酮终止12～20周妊娠的临床疗效。方法回顾性分析2010年1月～2010年10月的82例妊娠12～20周的孕妇在妇科实行药物流产的临床资料。结果全部82例妊娠12～20周的孕妇中有79(96.34%)例在服用米索前列醇2小时后胎儿胎盘娩出,并且出血少,无并发症。其余3(3.66%)例孕妇在服用米索前列醇3小时后胎儿胎盘无排出,实行钳刮术。结论米索前列醇联合米非司酮用于终止12～20周的妊娠,有效、安全、方便、容易掌握,值得在基层医院推广。
Objective To observe the clinical efficacy of misoprostol combined with mifepristone in terminating pregnancy at 12 to 20 weeks. Methods A retrospective analysis of 82 cases of pregnancy between January 2010 and October 2010 pregnant women pregnant women in the implementation of medical abortion clinical data. Results All 82 pregnant women with gestational age from 12 to 20 weeks had 79 (96.34%) cases of fetal placenta delivered 2 hours after taking misoprostol, and had less bleeding and no complications. The remaining 3 (3.66%) pregnant women taking misoprostol 3 hours after the fetus placenta without discharge, the implementation of forceps curettage. Conclusion Misoprostol combined with mifepristone for the termination of 12 to 20 weeks of pregnancy, effective, safe, convenient and easy to grasp, it is worth to promote in primary hospitals.